Market Place
Market Place
Post Enquiry
Enforcement Report - Week of September 4, 2024
04 Sep 2024 //
FDA
Kaylaan LLC Receives FDA Warning Letter
03 Sep 2024 //
FDA
FDA Issues Form 483 to Otsuka Pharmaceutical Co.
30 Aug 2024 //
FDA
Enforcement Report - Week of August 28, 2024
28 Aug 2024 //
FDA
FDA Issues Form 483 to Global Calcium Private
28 Aug 2024 //
FDA
EyePoint Pharmaceuticals Receives FDA Warning Letter
27 Aug 2024 //
FDA
CARsgen Therapeutics Receives FDA Warning Letter
27 Aug 2024 //
FDA
Berkeley Biologics Receives FDA Warning Letter
27 Aug 2024 //
FDA
Eugia Pharma Specialities Receives FDA Warning Letter
21 Aug 2024 //
FDA
Intercos Europe Receives FDA Warning Letter
21 Aug 2024 //
FDA
Enforcement Report - Week of August 21, 2024
21 Aug 2024 //
FDA
Veata Issues Voluntary Nationwide Recall of Endurance Sildenafil
21 Aug 2024 //
FDA
Boulla Issues Voluntary Nationwide Recall For Sildenafil
21 Aug 2024 //
FDA
Anhui Bayi Chemical Industry Fails EDQM inspection
16 Aug 2024 //
EDQM
Nowrez & Ismail Shukri Company Receives FDA Warning Letter
13 Aug 2024 //
FDA
LS Promotions Receives FDA Warning Letter
13 Aug 2024 //
FDA
FDA Issues Form 483 to Nubratori
08 Aug 2024 //
FDA
Enforcement Report for Week of August 7, 2024
07 Aug 2024 //
FDA
Velocity Pharma Receives FDA Warning Letter
06 Aug 2024 //
FDA
Velocity Pharma Receives FDA Warning Letter
06 Aug 2024 //
FDA
Guangzhou Baiyunshan Jingxiutang Pharmaceutical Receives FDA Warning Letter
06 Aug 2024 //
FDA
Enforcement Report - Week of July 31, 2024
31 Jul 2024 //
FDA
Spectrum Chemical on Health Canada Inspection List
30 Jul 2024 //
HEALTH CANADA
Strada Comertului Nr 7, Comuna Domnesti Fails EDQM Inspection
30 Jul 2024 //
EDQM
FDA Issues Form 483 to Hikma Injectables USA
26 Jul 2024 //
FDA
FDA Issues Form 483 to Carie Boyd Pharmaceuticals
26 Jul 2024 //
FDA
FDA Issues Form 483 to Brassica Pharma
25 Jul 2024 //
FDA
Enforcement Report - Week of July 24, 2024
24 Jul 2024 //
FDA
Brassica Pharma Receives FDA Warning Letter
23 Jul 2024 //
FDA
Triderma Pharma Receives FDA Warning Letter
23 Jul 2024 //
FDA
Yahon Enterprise Receives FDA Warning Letter
23 Jul 2024 //
FDA
Main Products Issues Voluntary Nationwide Recall of Umary Acido Hialuronico
22 Jul 2024 //
FDA
Endo Issues Voluntary Nationwide Recall of Clonazepam Tablets
17 Jul 2024 //
FDA
Enforcement Report - Week of July 17, 2024
17 Jul 2024 //
FDA
YangZhou SuXiang Medical Receives FDA Warning Letter
16 Jul 2024 //
FDA
Jiangsu Hengrui Pharma Receives FDA Warning Letter
16 Jul 2024 //
FDA
FDA Issues Form 483 to Lonza Group
15 Jul 2024 //
FDA
SoloVital.com Issues Voluntary Nationwide Recall of Umary Acido Hialuronica
15 Jul 2024 //
FDA
Shandong Boyuan Pharmaceutical on FDA Import Alert List
15 Jul 2024 //
FDA
Sun Pharmaceutical is on Health Canada Inspection List
12 Jul 2024 //
HEALTH CANADA
FDA Issues Form 483 to Samsung Biologic
11 Jul 2024 //
FDA
Optikem International Receives FDA Warning Letter
10 Jul 2024 //
FDA
reBom Receives FDA Warning Letter
10 Jul 2024 //
FDA
Enforcement Report - Week of July 10, 2024
10 Jul 2024 //
FDA
Baxter Issues Urgent Medical Device Recall for Life2000 Ventilator
10 Jul 2024 //
FDA
FDA Issues Form 483 to Hikma Pharmaceuticals USA
09 Jul 2024 //
FDA
Via Nibbiola Snc Fails EDQM Inspection
03 Jul 2024 //
EDQM
Sun Pharmaceutical Receives FDA Warning Letter
03 Jul 2024 //
FDA
Nowrez & Ismail Shukri is on FDA Import Alert List
03 Jul 2024 //
FDA
Emil Pharmaceutical Fails EDQM Inspection
02 Jul 2024 //
EDQM
FDA Issues Form 483 to Torrent Pharmaceuticals
26 Jun 2024 //
FDA
FDA Issues form 483 to Cipla Goa
26 Jun 2024 //
FDA
Glenmark USA Issues Voluntary Nationwide Recall for KCL ER Capsule
26 Jun 2024 //
FDA
Sani-Care Salon Products Receives FDA Warning Letter
26 Jun 2024 //
FDA
Enforcement Report - Week of June 26, 2024
26 Jun 2024 //
FDA
Blue Point Lab Issues Voluntary Nationwide Recall for Potassium Chloride
26 Jun 2024 //
FDA
